Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allison R Ayala

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Ophthalmology|December 21, 2016
ReplyJohn A Wells, Adam R Glassman, Allison R Ayala, et al.
Ophthalmology|March 25, 2017
ReplyJohn A Wells, Adam R Glassman, Neil M Bressler, et al.
JAMA Ophthalmology|October 7, 2016
Anti-Vascular Endothelial Growth Factor Comparative Effectiveness Trial for Diabetic Macular Edema: Additional Efficacy Post Hoc Analyses of a Randomized Clinical TrialLee M Jampol, Adam R Glassman, Neil M Bressler, et al.
Translational Vision Science & Technology|May 18, 2021
Tackling the Challenges of Product Development Through a Collaborative Rare Disease Network: The Foundation Fighting Blindness ConsortiumTodd A Durham, Jacque L Duncan, Allison R Ayala, et al.
Investigative Ophthalmology & Visual Science|March 16, 2022
The RUSH2A Study: Dark-Adapted Visual Fields in Patients With Retinal Degeneration Associated With Biallelic Variants in the USH2A GeneDavid G Birch, Lassana Samarakoon, Michele Melia, et al.
JAMA Ophthalmology|January 10, 2016
Persistent Macular Thickening After Ranibizumab Treatment for Diabetic Macular Edema With Vision ImpairmentSusan B Bressler, Allison R Ayala, Neil M Bressler, et al.
JAMA Ophthalmology|May 22, 2015
Assessing the Effect of Personalized Diabetes Risk Assessments During Ophthalmologic Visits on Glycemic Control: A Randomized Clinical TrialLloyd Paul Aiello, Allison R Ayala, Andrew N Antoszyk, et al.
Investigative Ophthalmology & Visual Science|August 12, 2025
Progression of Dark-Adapted Visual Fields Over 3 Years in the Rate of Progression in USH2A-Related Retinal Degeneration (RUSH2A) StudyDavid G Birch, Jacque L Duncan, Lassana Samarakoon, et al.
Ophthalmology|March 4, 2016
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical TrialJohn A Wells, Adam R Glassman, Allison R Ayala, et al.
Cornea|March 28, 2025
Central Cornea Changes on Anterior Segment OCT and In Vivo Confocal Microscopy After Autologous Limbal Epithelial Cell TransplantationLeyla Yavuz Saricay, Aaron R Kaufman, Lynette K Johns, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Ophthalmology|December 21, 2016
ReplyJohn A Wells, Adam R Glassman, Allison R Ayala, et al.
Ophthalmology|March 25, 2017
ReplyJohn A Wells, Adam R Glassman, Neil M Bressler, et al.
JAMA Ophthalmology|October 7, 2016
Anti-Vascular Endothelial Growth Factor Comparative Effectiveness Trial for Diabetic Macular Edema: Additional Efficacy Post Hoc Analyses of a Randomized Clinical TrialLee M Jampol, Adam R Glassman, Neil M Bressler, et al.
Translational Vision Science & Technology|May 18, 2021
Tackling the Challenges of Product Development Through a Collaborative Rare Disease Network: The Foundation Fighting Blindness ConsortiumTodd A Durham, Jacque L Duncan, Allison R Ayala, et al.
Investigative Ophthalmology & Visual Science|March 16, 2022
The RUSH2A Study: Dark-Adapted Visual Fields in Patients With Retinal Degeneration Associated With Biallelic Variants in the USH2A GeneDavid G Birch, Lassana Samarakoon, Michele Melia, et al.
JAMA Ophthalmology|January 10, 2016
Persistent Macular Thickening After Ranibizumab Treatment for Diabetic Macular Edema With Vision ImpairmentSusan B Bressler, Allison R Ayala, Neil M Bressler, et al.
JAMA Ophthalmology|May 22, 2015
Assessing the Effect of Personalized Diabetes Risk Assessments During Ophthalmologic Visits on Glycemic Control: A Randomized Clinical TrialLloyd Paul Aiello, Allison R Ayala, Andrew N Antoszyk, et al.
Investigative Ophthalmology & Visual Science|August 12, 2025
Progression of Dark-Adapted Visual Fields Over 3 Years in the Rate of Progression in USH2A-Related Retinal Degeneration (RUSH2A) StudyDavid G Birch, Jacque L Duncan, Lassana Samarakoon, et al.
Ophthalmology|March 4, 2016
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical TrialJohn A Wells, Adam R Glassman, Allison R Ayala, et al.
Cornea|March 28, 2025
Central Cornea Changes on Anterior Segment OCT and In Vivo Confocal Microscopy After Autologous Limbal Epithelial Cell TransplantationLeyla Yavuz Saricay, Aaron R Kaufman, Lynette K Johns, et al.
Pageof 4